ArticleAnnals of surgical oncology2026
Disparities in Active Surveillance of Papillary Thyroid Microcarcinomas.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPapillary thyroid microcarcinomas (PTMC) are small, typically indolent tumors that may be managed with surgery or active surveillance. However, active surveillance (AS) is resource intensive. We hypothesized that socioeconomic factors would affect likelihood of management with AS. PATIENTS AND
methodsThe National Cancer Database (NCDB) was queried to identify all patients with PTMCs larger than 3 mm treated between 2004 and 2024. Patients were divided into two groups: upfront surgery and AS. Demographics and facility level variables were compared between groups. Multivariable logistic regressions were applied to identify independent predictors of treatment with AS.
resultsThere were 64,463 patients treated for PTMC in the study period; 399 (0.6%) were managed with AS. The AS group had a higher proportion of Asian patients (16.0% vs. 7.1%) and a lower proportion of Black patients (2.0% vs. 6.4%) (P < 0.001). The majority (89.2%) of AS patients were treated at academic centers, compared with fewer than half (41.0%, P < 0.001) of surgery patients. Multivariable analysis showed Black race (adjusted odds ratio (aOR) 0.40, 95% CI 0.23-0.68, P < 0.01) and lower neighborhood socioeconomic status were associated with decreased likelihood of treatment with AS. Traveling farther for care (aOR 1.09 per 100 miles, (95% CI 1.07-1.12, P < 0.001)) was associated with increased odds of treatment with AS.
conclusionsBlack and Hispanic patients as well as patients from neighborhoods with lower median income are less likely to be treated with AS for PTMC. In contrast, patients traveling farther for care and being treated at academic centers were more likely to undergo AS, suggesting that socioeconomically advantaged patients may be traveling to high volume academic centers and choosing AS.
Identifiers
42649446What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.